Healthcare AI just had one of its biggest funding weeks of 2026. Most healthcare executives still have no idea what was just funded — or why it matters.
This is the pattern that keeps repeating. Capital flows into healthcare AI at a pace that outstrips the attention of the clinical and operational leaders who will ultimately decide whether these tools get deployed. By the time a health system is evaluating a vendor, that vendor has already completed multiple funding rounds, built a significant customer base, and established the market position that will define the competitive landscape for years.
📊 The May 2026 funding week included over $500 million in disclosed deals across diagnostics, clinical decision support, revenue cycle automation, and care navigation. The headline transaction was Iterative Health's $77 million Series C, led by Google Ventures and Insight Partners, for AI-powered GI diagnostics that detect polyps and lesions missed by human endoscopists. But the deals below th…
